in the report they indicated that they added to their position post result announcement. Milford has done the same by buying more on market given the strength of the results. Two of NEU’s key institutional backers double down on their investment post phase 3 results - what does it tell you?
- Forums
- ASX - By Stock
- NEU
- A De-risked bio-tech with 4X upside - Karst Peak Capital
NEU
neuren pharmaceuticals limited
Add to My Watchlist
3.71%
!
$15.39

A De-risked bio-tech with 4X upside - Karst Peak Capital, page-9
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$15.39 |
Change
0.550(3.71%) |
Mkt cap ! $1.915B |
Open | High | Low | Value | Volume |
$15.00 | $15.50 | $14.91 | $9.641M | 631.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 300 | $15.34 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.39 | 1224 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10 | 15.100 |
1 | 665 | 15.020 |
2 | 537 | 15.000 |
1 | 2000 | 14.970 |
1 | 750 | 14.850 |
Price($) | Vol. | No. |
---|---|---|
15.390 | 1224 | 1 |
15.450 | 265 | 1 |
15.490 | 357 | 1 |
15.500 | 8401 | 7 |
15.530 | 35 | 1 |
Last trade - 16.10pm 18/07/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |